Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer

Conditions:   Colorectal Cancer;   Metastatic Colorectal Cancer;   Colon Cancer Interventions:   Drug: Regorafenib;   Drug: Nivolumab Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   Bristol-Myers Squibb Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials